26 July 2022, 07:30 CEST Adelaide, Australia and Liege, Belgium – Mayne Pharma Group Limited (ASX: MYX) and Mithra Pharmaceuticals, SA (Euronext Brussels: MITRA) are pleased to announce NEXTSTELLIS® (14.2 mg of estetrol and 3 mg drospirenone tablets), the first-of-its-kind oral contraceptive with a novel estrogen, is now available in Australia.

Liege, Belgium, 6 July 2022 – 17:45 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces a change in its Board of Directors’ Chairmanship. Following the resignation with immediate effect of Mr. Ajit Shetty for personal reasons nonrelated to the Company, the Board of Directors approved, on the proposal of the outgoing Chairman and the recommendation of the Nomination and Remuneration Committee, the appointment of Mr. Christian Moretti as Chairman, as well as that of Mr. Erik Van Den Eynden as Vice-Chairman. These functions will be exercised until the next Company’s Shareholders Meeting in May 2023 called to deliberate on the renewal of the Board at the end of the members’ terms of office.